REPORT ID 922

EMEA (Europe, Middle East and Africa) Injectable Anticoagulants Market Report 2017

Publish Date
04-Dec-17
Pages
106
Format
Electronic (PDF)

In this report, the EMEA Injectable Anticoagulants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Injectable Anticoagulants for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Injectable Anticoagulants market competition by top manufacturers/players, with Injectable Anticoagulants sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Sanofi
    Genentech (Roche)
    Boehringer Ingelheim
    Pfizer
    The Medicines Company?
    Aspen
    Otsuka
    ...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Low-molecular-weight Heparin (LMWH)
    Direct Thrombin Inhibitor (DTI)
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    VTE
    ACS/MI
    AF
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Injectable Anticoagulants Market Report 2017
1 Injectable Anticoagulants Overview
    1.1 Product Overview and Scope of Injectable Anticoagulants
    1.2 Classification of Injectable Anticoagulants
        1.2.1 EMEA Injectable Anticoagulants Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Injectable Anticoagulants Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Low-molecular-weight Heparin (LMWH)
        1.2.4 Direct Thrombin Inhibitor (DTI)
        1.2.5 Other
    1.3 EMEA Injectable Anticoagulants Market by Application/End Users
        1.3.1 EMEA Injectable Anticoagulants Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 VTE
        1.3.3 ACS/MI
        1.3.4 AF
        1.3.5 Other
    1.4 EMEA Injectable Anticoagulants Market by Region
        1.4.1 EMEA Injectable Anticoagulants Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Injectable Anticoagulants (2012-2022)
        1.5.1 EMEA Injectable Anticoagulants Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Injectable Anticoagulants Revenue and Growth Rate (2012-2022)

2 EMEA Injectable Anticoagulants Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Injectable Anticoagulants Market Competition by Players/Manufacturers
        2.1.1 EMEA Injectable Anticoagulants Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Injectable Anticoagulants Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Injectable Anticoagulants Sale Price by Players (2012-2017)
    2.2 EMEA Injectable Anticoagulants (Volume and Value) by Type/Product Category
        2.2.1 EMEA Injectable Anticoagulants Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Injectable Anticoagulants Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Injectable Anticoagulants Sale Price by Type (2012-2017)
    2.3 EMEA Injectable Anticoagulants (Volume) by Application
    2.4 EMEA Injectable Anticoagulants (Volume and Value) by Region
        2.4.1 EMEA Injectable Anticoagulants Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Injectable Anticoagulants Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Injectable Anticoagulants Sales Price by Region (2012-2017)

3 Europe Injectable Anticoagulants (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Injectable Anticoagulants Sales and Value (2012-2017)
        3.1.1 Europe Injectable Anticoagulants Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Injectable Anticoagulants Revenue and Growth Rate (2012-2017)
    3.2 Europe Injectable Anticoagulants Sales and Market Share by Type
    3.3 Europe Injectable Anticoagulants Sales and Market Share by Application
    3.4 Europe Injectable Anticoagulants Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Injectable Anticoagulants Sales Volume by Countries (2012-2017)
        3.4.2 Europe Injectable Anticoagulants Revenue by Countries (2012-2017)
        3.4.3 Germany Injectable Anticoagulants Sales and Growth Rate (2012-2017)
        3.4.4 France Injectable Anticoagulants Sales and Growth Rate (2012-2017)
        3.4.5 UK Injectable Anticoagulants Sales and Growth Rate (2012-2017)
        3.4.6 Russia Injectable Anticoagulants Sales and Growth Rate (2012-2017)
        3.4.7 Italy Injectable Anticoagulants Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Injectable Anticoagulants Sales and Growth Rate (2012-2017)

4 Middle East Injectable Anticoagulants (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Injectable Anticoagulants Sales and Value (2012-2017)
        4.1.1 Middle East Injectable Anticoagulants Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Injectable Anticoagulants Revenue and Growth Rate (2012-2017)
    4.2 Middle East Injectable Anticoagulants Sales and Market Share by Type
    4.3 Middle East Injectable Anticoagulants Sales and Market Share by Application
    4.4 Middle East Injectable Anticoagulants Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Injectable Anticoagulants Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Injectable Anticoagulants Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Injectable Anticoagulants Sales and Growth Rate (2012-2017)
        4.4.4 Israel Injectable Anticoagulants Sales and Growth Rate (2012-2017)
        4.4.5 UAE Injectable Anticoagulants Sales and Growth Rate (2012-2017)
        4.4.6 Iran Injectable Anticoagulants Sales and Growth Rate (2012-2017)

5 Africa Injectable Anticoagulants (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Injectable Anticoagulants Sales and Value (2012-2017)
        5.1.1 Africa Injectable Anticoagulants Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Injectable Anticoagulants Revenue and Growth Rate (2012-2017)
    5.2 Africa Injectable Anticoagulants Sales and Market Share by Type
    5.3 Africa Injectable Anticoagulants Sales and Market Share by Application
    5.4 Africa Injectable Anticoagulants Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Injectable Anticoagulants Sales Volume by Countries (2012-2017)
        5.4.2 Africa Injectable Anticoagulants Revenue by Countries (2012-2017)
        5.4.3 South Africa Injectable Anticoagulants Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Injectable Anticoagulants Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Injectable Anticoagulants Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Injectable Anticoagulants Sales and Growth Rate (2012-2017)

6 EMEA Injectable Anticoagulants Manufacturers/Players Profiles and Sales Data
    6.1 Sanofi
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Injectable Anticoagulants Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Sanofi Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Genentech (Roche)
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Injectable Anticoagulants Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Genentech (Roche) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Boehringer Ingelheim
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Injectable Anticoagulants Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Boehringer Ingelheim Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Pfizer
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Injectable Anticoagulants Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Pfizer Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 The Medicines Company?
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Injectable Anticoagulants Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 The Medicines Company? Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Aspen
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Injectable Anticoagulants Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Aspen Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Otsuka
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Injectable Anticoagulants Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Otsuka Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    ...

7 Injectable Anticoagulants Manufacturing Cost Analysis
    7.1 Injectable Anticoagulants Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Injectable Anticoagulants

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Injectable Anticoagulants Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Injectable Anticoagulants Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Injectable Anticoagulants Market Forecast (2017-2022)
    11.1 EMEA Injectable Anticoagulants Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Injectable Anticoagulants Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Injectable Anticoagulants Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Injectable Anticoagulants Price and Trend Forecast (2017-2022)
    11.2 EMEA Injectable Anticoagulants Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Injectable Anticoagulants Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Injectable Anticoagulants Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Injectable Anticoagulants Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Injectable Anticoagulants Sales Forecast by Type (2017-2022)
    11.7 EMEA Injectable Anticoagulants Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer